JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A9502 OTS964 hydrochloride
1 Citation

Summary: TOPK inhibitor,potent and selective

≥88.6 mg/mL
B4888 Obeticholic Acid
2 Citation

Target: Farnesoid X receptors (FXRs)

Summary: FXR agonist with anticholeretic activity

≥21.5 mg/mL
B4889 Verdinexor (KPT-335)

Summary: XPO1/CRM1 inhibitor

≥44.2 mg/mL
B4900 Indoximod (NLG-8189)

Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor

insoluble in DMSO; insoluble in EtOH; ≥1.12 mg/mL
B4924 TA 02

Summary: p38 MAPK inhibitor

insoluble in H2O; ≥12.65 mg/mL
B4932 JJKK 048

Summary: monoacylglycerol lipase (MAGL) inhibitor

Soluble in DMSO
B4936 CKI 7 dihydrochloride
2 Citation

Summary: Casein kinase 1 (CK1) inhibitor

<17.93 mg/mL
B4944 AZD 3988

Summary: diacylglycerol acyltransferase (DGAT-1) inhibitor

<45.64 mg/mL
A8711 DDD107498
5 Citation

Target: Eukaryotic elongation factors

Summary: A novelmultiple-stage antimalarial agent

insoluble in H2O; ≥14.05 mg/mL
B5823 LP533401 hcl

Target: Tph

Summary: Tph-1 inhibitor

≥56.3 mg/mL